| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |